A Study of IMP4297 in Patients With Advanced Solid Tumors

Clinical trial NCT03508011 · COMPLETED

Trial details

NCT number: NCT03508011
Sponsor: Impact Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumours Breast Cancer Ovarian Cancer Prostate Cancer

Start date: 2017-08-23
Primary completion: 2020-12-16
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.